Cellisys EX Wrinkle Solution Eye Contour

Manufacturer
DN Company Co., Ltd. | Cosmax, Inc.
Effective date
2019-03-21
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
legacy-cache
Hydrated at
2026-08-02 00:29:05

Label at a glance#

ProductCellisys EX Wrinkle Solution Eye Contour EGF
Active ingredientDimethicone
Label structure8 sections

Indications and uses

INDICATION AND USAGE: Tighten the lid after using it. Don't keep it in the place where the temperature is extremely hot or low and exposed to the direct sunlight.

Dosage and administration

DOSAGE AND ADMINISTRATION: After essence step or cream step, take an appropriate amount and apply to the area around eyes with patting thoroughly to let it absorb into the skin.

Label contents#

Full prescribing information#

ACTIVE INGREDIENT

OTC - ACTIVE INGREDIENT SECTION

ACTIVE INGREDIENT: Dimethicone 1%

INACTIVE INGREDIENT

INACTIVE INGREDIENT SECTION

INACTIVE INGREDIENTS: Water, Ethylhexyl Palmitate, Butylene Glycol, Glycerin, Cetyl Ethylhexanoate, Butyrospermum Parkii (Shea) Butter, Petrolatum, Niacinamide, Behenyl Alcohol, Beeswax, HDI/Trimethylol Hexyllactone Crosspolymer, Cetearyl Alcohol, Glyceryl Stearate, Polysorbate 60, Cucurbita Pepo (Pumpkin) Seed Oil, Glycine Soja (Soybean) Seed Extract, Sigesbeckia Orientalis Extract, Rabdosia Rubescens Extract, Vigna Radiata Seed Extract, Cucumis Sativus (Cucumber) Fruit Extract, Actinidia Polygama Fruit Extract, Pentylene Glycol, Polyacrylate-13, PEG-100 Stearate, Sorbitan Sesquioleate, Polyisobutene, Caprylyl Glycol, Caprylic/Capric Triglyceride, Polysorbate 20, Silica, Adenosine, Hydrogenated Lecithin, Potassium Cetyl Phosphate, Sodium Ascorbyl Phosphate, sh-Oligopeptide-1, Ceramide 3, Palmitoyl Tripeptide-5, Palmitoyl Oligopeptide, Palmitoyl Tetrapeptide-7, Alcohol Denat., Xanthan Gum, BHT, Alcohol, Carbomer, Disodium EDTA, Fragrance (Parfum), Yellow 5 (CI 19140), Yellow 6 (CI 15985)

PURPOSE

OTC - PURPOSE SECTION

PURPOSE: Skin protectant

WARNINGS

WARNINGS SECTION

WARNING: For external use only. Avoid contact with eyes. Discontinue use if signs of irritation or rash appear. Keep out of reach of babies and children.

KEEP OUT OF REACH OF CHILDREN

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of babies and children.

INDICATIONS AND USAGE

INDICATIONS & USAGE SECTION

INDICATION AND USAGE: Tighten the lid after using it. Don't keep it in the place where the temperature is extremely hot or low and exposed to the direct sunlight.

DOSAGE AND ADMINISTRATION

DOSAGE & ADMINISTRATION SECTION

DOSAGE AND ADMINISTRATION: After essence step or cream step, take an appropriate amount and apply to the area around eyes with patting thoroughly to let it absorb into the skin.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Image of cartonImage of carton

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
DimethiconeACTIVE INGREDIENT92RU3N3Y1O1
DIMETHICONEACTIVE MOIETY92RU3N3Y1O1
Ethylhexyl PalmitateINACTIVE INGREDIENT28659933091
WaterINACTIVE INGREDIENT059QF0KO0R1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 4 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
60565-06060565-060-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 3 matching rows.

Name, UNII, Kind table
NameUNIIKind
Dimethicone92RU3N3Y1OACTIB
Water059QF0KO0RIACT
Ethylhexyl Palmitate2865993309IACT

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
6f8b1383-958c-4360-bb26-44ed6fe85582347db45f-b78a-4504-a593-4cd112c44e2c2022-11-10WarningsExact identifier
spl set id: 347db45f-b78a-4504-a593-4cd112c44e2c

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.